Generic Pharmasec - Genpharmasec Share Price

1.11-0.03 (-2.63%)

BSE

Closed
As On:
As On: 25 Jun, 2026, 03:57 PM IST

Sector: Chemicals
Industry: Dyes & Pigments

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	-
High	-
Low	-
Prev Close	-
Volume	-
VWAP(₹)	-

Share Price	Value
Today/Current/Last	-1.11
Previous Day	-1.14

Generic Pharmasec Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Generic Pharmasec Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	56.44	40.81	33.10	12.74	14.95
Total Income Growth (%)	38.31	23.29	159.87	-14.78	60.78
Total Expenses	54.11	41.73	33.67	11.37	15.27
Total Expenses Growth (%)	29.67	23.93	196.17	-25.52	94.53
EBIT	2.33	-0.92	-0.57	1.37	-0.32
EBIT Growth (%)	-	-	-141.70	-	-122.05
Profit after Tax (PAT)	1.23	-0.43	-1.18	1.22	-0.27
PAT Growth (%)	-	-	-196.79	-	-134.74
EBIT Margin (%)	4.13	-2.26	-1.72	10.74	-2.14
Net Profit Margin (%)	2.17	-1.06	-3.55	9.54	-1.81
Basic EPS (₹)	0.02	-0.02	-0.02	0.02	-0.01

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	53.28	37.44	32.56	12.94	14.62
Total Income Growth (%)	42.32	14.97	151.74	-11.50	57.72
Total Expenses	50.17	36.76	31.10	11.15	14.59
Total Expenses Growth (%)	36.49	18.18	178.89	-23.57	96.55
EBIT	3.11	0.68	1.46	1.78	0.02
EBIT Growth (%)	358.33	-53.50	-18.14	0.00	-98.68
Profit after Tax (PAT)	2.32	0.76	0.82	1.56	-0.23
PAT Growth (%)	206.46	-7.29	-47.67	-	-120.11
EBIT Margin (%)	5.84	1.81	4.48	13.78	0.17
Net Profit Margin (%)	4.35	2.02	2.51	12.05	-1.55
Basic EPS (₹)	0.04	0.01	0.01	0.03	0.00

	FY 2026	FY 2025
Total Revenue	143.09	36.78
Total Revenue Growth (%)	289.01	18.42
Total Expenses	142.12	34.90
Total Expenses Growth (%)	307.19	13.28
Profit after Tax (PAT)	1.60	1.21
PAT Growth (%)	32.71	-
Operating Profit Margin (%)	1.57	6.86
Net Profit Margin (%)	1.14	3.58
Basic EPS (₹)	0.01	0.02

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	136.22	36.39	31.12	25.62	27.41
Total Revenue Growth (%)	274.31	16.93	21.50	-6.56	26.71
Total Expenses	129.78	32.95	30.66	25.33	27.86
Total Expenses Growth (%)	293.93	7.46	21.01	-9.05	38.41
Profit after Tax (PAT)	5.45	2.47	0.05	1.12	-0.21
PAT Growth (%)	120.74	5,243.72	-95.89	-	-116.64
Operating Profit Margin (%)	5.35	11.29	2.83	1.32	-1.62
Net Profit Margin (%)	4.14	7.48	0.15	4.40	-0.76
Basic EPS (₹)	0.10	0.04	0.00	0.04	-0.01

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 274.31% outperformed its 3 year CAGR of 73.58%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 2.77% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025
Total Assets	138.15	79.89
Total Assets Growth (%)	72.92	12.33
Total Liabilities	72.51	14.61
Total Liabilities Growth (%)	396.20	121.72
Total Equity	65.64	65.28
Total Equity Growth (%)	0.56	1.15
Current Ratio (x)	1.71	2.78
Total Debt to Equity (x)	0.50	0.05
Contingent Liabilities	0.00	0.02

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	110.06	79.09	70.47	19.88	21.65
Total Assets Growth (%)	39.16	12.23	254.48	-8.18	-22.18
Total Liabilities	38.56	12.54	5.91	4.54	6.28
Total Liabilities Growth (%)	207.50	112.18	30.18	-27.71	-12.29
Total Equity	71.50	66.55	64.57	15.33	15.37
Total Equity Growth (%)	7.44	3.07	321.20	-0.26	-25.61
Current Ratio (x)	1.83	3.01	14.85	9.17	3.43
Total Debt to Equity (x)	0.05	0.05	0.05	0.20	0.00
Contingent Liabilities	0.00	0.02	0.02	-	-

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025
Net Cash flow from Operating Activities	-17.55	2.99
Net Cash used in Investing Activities	13.26	-15.30
Net Cash flow from Financing Activities	3.92	-1.25
Net Cash Flow	-0.37	-13.56
Closing Cash & Cash Equivalent	0.97	5.27
Closing Cash & Cash Equivalent Growth (%)	-81.52	-72.01
Total Debt/ CFO (x)	-1.88	1.05

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	1.93	3.45	-2.27	-3.23	-2.34
Net Cash used in Investing Activities	-1.64	-16.45	-29.03	0.54	0.42
Net Cash flow from Financing Activities	-0.02	-0.44	47.89	3.08	-
Net Cash Flow	0.27	-13.44	16.59	0.39	-1.93
Closing Cash & Cash Equivalent	0.79	5.14	18.58	1.99	1.61
Closing Cash & Cash Equivalent Growth (%)	-84.62	-72.31	832.15	23.98	-54.50
Total Debt/ CFO (x)	2.04	0.91	-1.41	-0.95	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2026	FY 2025
Return on Equity (%)	2.41	1.85
Return on Capital Employed (%)	2.42	3.30
Return on Assets (%)	1.16	1.51
Interest Coverage Ratio (x)	3.53	7.19
Asset Turnover Ratio (x)	1.28	0.45
Price to Earnings (x)	27.03	86.96
Price to Book (x)	0.65	1.61
EV/EBITDA (x)	14.95	32.83
EBITDA Margin (%)	3.12	9.27

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	7.62	3.70	0.07	7.33	-1.36
Return on Capital Employed (%)	9.21	5.33	1.27	1.89	-2.88
Return on Assets (%)	4.95	3.12	0.06	5.65	-0.96
Interest Coverage Ratio (x)	12.28	13.90	2.23	6.38	0.00
Asset Turnover Ratio (x)	1.39	0.44	0.67	1.23	1.10
Price to Earnings (x)	7.93	42.55	3,333.33	76.92	-769.23
Price to Book (x)	0.60	1.57	1.91	5.62	9.91
EV/EBITDA (x)	5.19	26.61	123.13	244.03	-351.37
EBITDA Margin (%)	5.54	11.70	2.88	1.40	-1.56

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Generic Pharmasec	73.73	0.93	2.41	2.42	1.16	76.42	1.57	0.40	0.01	1.71	0.50	-1.88
Polson	28.83	3.01	13.57	15.65	3.42	2.51	15.72	5.78	514.17	1.24	2.00	0.00
Shree Hari Chem	16.85	1.57	9.29	13.84	3.84	21.68	3.98	2.23	8.03	0.95	0.74	4.97
Yash Chemex Ltd.	26.84	0.89	4.92	7.33	2.08	17.12	3.23	1.71	1.97	2.35	0.37	35.68
Camex Ltd	13.21	0.93	7.04	10.02	4.55	3.82	3.50	2.17	3.21	3.00	0.15	-2.39
Add More

Annual Ratios (%)

Choose from Peers

Shreyas Intermediates
Daikaffil Chem
Dynamic Ind
Vivid Global
Pratiksha Chem

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Generic Pharmasec Stock Performance	-2.63	0.00	-5.93	-11.20	-50.88	-64.76	-86.66
Polson Stock Performance	3.57	-3.89	-2.63	-0.87	-12.76	1.74	19.31
Shree Hari Chem Stock Performance	-4.39	2.38	-1.36	0.00	-29.87	112.41	62.33
Yash Chemex Ltd. Stock Performance	5.89	-1.49	-0.95	-14.94	2.46	-22.55	17.15
Camex Ltd Stock Performance	-1.26	-1.08	32.81	44.10	7.80	69.78	16.40
Add More

Category	No. of Shares	Percentage
Promoters	16,60,01,000	29.98 %
Pledge	0	0.00 %
Others	38,77,18,700	70.02 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	29.98	29.98	29.98	29.98
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	70.02	70.02	70.02	70.02

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
May 13, 2026
Board Meeting
Quarterly Results
Feb 02, 2026
Board Meeting
Quarterly Results
Oct 27, 2025

Board Meetings

Announced on	Meeting on
May 13, 2026	May 21, 2026
Audited Results
Feb 02, 2026	Feb 09, 2026
Quarterly Results
Oct 27, 2025	Nov 06, 2025
Quarterly Results
Aug 28, 2025	Sep 02, 2025
Others
Aug 01, 2025	Aug 07, 2025
Quarterly Results

Dividends
No Data Available
Bonus
No Data Available
Splits
Announced on Ex-Date
Feb 28, 2019 Apr 11, 2019
Split: Old FV10.0| New FV:1.0
Rights
Announced on Ex-Date
Jun 05, 2023 Jan 09, 2024
Rights ratio: 1 share for every 1 held at a price of Rs 1.75

Announced on	Ex-Date
Feb 28, 2019	Apr 11, 2019
Split: Old FV10.0\| New FV:1.0

Announced on	Ex-Date
Jun 05, 2023	Jan 09, 2024
Rights ratio: 1 share for every 1 held at a price of Rs 1.75

AGM/EGM Meetings

Announced on	Meeting on
Sep 10, 2025	Sep 29, 2025
-
Jun 27, 2024	Jul 23, 2024
Book closure from Jul 17, 2024 to Jul 23, 2024
Sep 01, 2023	Sep 23, 2023
A.G.M.
May 09, 2023	Jun 02, 2023
Book closure from May 26, 2023 to Jun 2, 2023
Sep 05, 2022	Sep 29, 2022
-

About Generic Pharmasec

Genpharmasec Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 61.46 Crore) operating in Chemicals sector.

Genpharmasec Ltd. key Products/Revenue Segments include Diagnostics and Income From Sale Of Share & Securities for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 56.44 Crore, up 38.31 % from last quarter Total Income of Rs 40.81 Crore and up 277.65 % from last year same quarter Total Income of Rs 14.95 Crore. Company has reported net profit after tax of Rs 1.35 Crore in latest quarter.

The company’s top management includes Mr.Sohan Chaturvedi, Mr.Rajesh Sadhwani, Mrs.Sneha Sadhwani, Mr.Mayur Bhatt, Mr.Sachin Aphandkar, Mr.Siddhesh Shende, Mr.Hardik Makwana. Company has Koshal & Associates as its auditors. As on 31-03-2026, the company has a total of 55.37 Crore shares outstanding.

Generic Pharmasec Share Price Today is Rs. 1.11. On previous day, the Generic Pharmasec Share Price (NSE) closed at Rs. 1.14, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 29.98% of the stake in Generic Pharmasec shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Generic Pharmasec stocks was 0.0% as compared to 0.0% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Generic Pharmasec shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Generic Pharmasec stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Generic Pharmasec Dividend: Ever since 1992, Generic Pharmasec dividends has been paid out around 0 times. As on 25 Jun, 2026, 03:57 PM IST, The overall dividend yield for Generic Pharmasec stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 0.02.

Generic Pharmasec Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 56.44 Cr. of sales and 38.31% of quarterly net profit, there have been multiple ups and downs in the Generic Pharmasec stock prices in the past few weeks. For example, Generic Pharmasec stock price on 18th of June 2026 was around Rs. 1.13. Generic Pharmasec share price now stands at an average of Rs. 1.11. Judging by last week's performance, stock is in up trend.

Generic Pharmasec has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Generic Pharmasec share.

Historical Prices and Performance:
Generic Pharmasec, incorporated in 1992 is a Small Cap company (with a market cap of Rs. 61.46) operating in Chemicals sector.
The Return of Equity (ROE) in last five financial years given by Generic Pharmasec stock was 2.41%, 1.85%, -0.19%, 7.33% and -1.36% respectively.
The Generic Pharmasec share gave a 3 year return of -68.91% as compared to Nifty 50 which gave a return of 28.88%.
Generic Pharmasec announced 0.0% final dividend on null.

Key Metrics:
PE Ratio of Generic Pharmasec is 75.06
Prices/Sales Ratio of Generic Pharmasec is 0.31
Price/Book Ratio of Generic Pharmasec is 0.95

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at 75.06 and 0.95 respectively.

Leadership of Generic Pharmasec :
Hardik Makwana is Co. Secretary & Compl. Officer
Sohan Chaturvedi is WholeTime Director & CFO
Sneha Sadhwani is Non Exe.Non Ind.Director
Rajesh Sadhwani is Non Exe.Non Ind.Director
Siddhesh Shende is Independent Director
Mayur Bhatt is Independent Director
Sachin Aphandkar is Independent Director
Hardik Makwana is Co. Secretary & Compl. Officer
Sohan Chaturvedi is WholeTime Director & CFO
Sneha Sadhwani is Non Exe.Non Ind.Director
Rajesh Sadhwani is Non Exe.Non Ind.Director
Siddhesh Shende is Independent Director
Mayur Bhatt is Independent Director
Sachin Aphandkar is Independent Director
Hardik Makwana is Co. Secretary & Compl. Officer
Sohan Chaturvedi is WholeTime Director & CFO
Sneha Sadhwani is Non Exe.Non Ind.Director
Rajesh Sadhwani is Non Exe.Non Ind.Director
Siddhesh Shende is Independent Director
Mayur Bhatt is Independent Director
Sachin Aphandkar is Independent Director
Hardik Makwana is Co. Secretary & Compl. Officer
Sohan Chaturvedi is WholeTime Director & CFO
Sneha Sadhwani is Non Exe.Non Ind.Director
Rajesh Sadhwani is Non Exe.Non Ind.Director
Siddhesh Shende is Independent Director
Mayur Bhatt is Independent Director
Sachin Aphandkar is Independent Director
Hardik Makwana is Co. Secretary & Compl. Officer
Sohan Chaturvedi is WholeTime Director & CFO
Sneha Sadhwani is Non Exe.Non Ind.Director
Rajesh Sadhwani is Non Exe.Non Ind.Director
Siddhesh Shende is Independent Director
Mayur Bhatt is Independent Director
Sachin Aphandkar is Independent Director
Hardik Makwana is Co. Secretary & Compl. Officer
Sohan Chaturvedi is WholeTime Director & CFO
Sneha Sadhwani is Non Exe.Non Ind.Director
Rajesh Sadhwani is Non Exe.Non Ind.Director
Siddhesh Shende is Independent Director
Mayur Bhatt is Independent Director
Sachin Aphandkar is Independent Director
Hardik Makwana is Co. Secretary & Compl. Officer
Sohan Chaturvedi is WholeTime Director & CFO
Sneha Sadhwani is Non Exe.Non Ind.Director
Rajesh Sadhwani is Non Exe.Non Ind.Director
Siddhesh Shende is Independent Director
Mayur Bhatt is Independent Director
Sachin Aphandkar is Independent Director
Hardik Makwana is Co. Secretary & Compl. Officer
Sohan Chaturvedi is WholeTime Director & CFO
Sneha Sadhwani is Non Exe.Non Ind.Director
Rajesh Sadhwani is Non Exe.Non Ind.Director
Siddhesh Shende is Independent Director
Mayur Bhatt is Independent Director
Sachin Aphandkar is Independent Director

Industry

Dyes & Pigments

Key Indices Listed On

-

Address

Office No. 104 & 105 (1st Floor),Gundecha Industrial Premises Co-Operative Society Ltd.,Akurli Road, Kandivali (East),Mumbai, Maharashtra - 400101

Contact

compliance@genpharmasec.com

www.genpharmasec.com

PE Ratio(x)	73.73
EPS - TTM(₹)	0.02
MCap(₹ Cr.)	61.46
MCap Rank	130
PB Ratio(x)	0.95
Div Yield(%)	-
Face Value(₹)	1.00
52W High(₹)	2.20
52W Low(₹)	0.75
MCap/Sales	0.31
Beta(1 Month)	0.51
BV/Share(₹)	1.19

1 Day	-2.63%
1 Month	-15.27%
3 Months	21.98%
1 Year	-46.38%
3 Years	-68.19%
5 Years	-87.54%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Generic Pharmasec - Genpharmasec Share Price

Key Metrics

Generic Pharmasec share price insights

Generic Pharmasec Share Price Returns

Generic Pharmasec Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Generic Pharmasec Top Searches

Corporate Actions

About Generic Pharmasec

Executive Leadership

Auditors

FAQs about Generic Pharmasec share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News